We have compiled a bank of guidance, information and resources that our members may find useful in keeping up to date on the latest information and guidance to help you manage your businesses during the Covid-19 pandemic.
The list is divided into:
- Business Intelligence Associations - UK
- Business Intelligence Associations - International
- Data Protection Regulators
- Pharmaceutical Industry Associations
- BHBIA Member Companies (research and trackers)
If you would like to contribute an item that would be of interest to our business intelligence audience, please contact us - we just need a one-line headline, a short description (up to 75 words) and a link to further details.
Latest additions - April 2021:
Links to these resources are provided for information purposes only. The BHBIA’s decision to make this information available does not infer endorsement of any of the content and nor do we accept any responsibility for its accuracy. This is not an exhaustive list of all the relevant information that's available - we welcome further suggestions for inclusion.
Business Intelligence Associations - UK
This joint statement from the Chairs of the BHBIA Board, Ethics & Compliance Committee and Fieldwork Forum gives you our latest advice on navigating the current public health crisis.
Now that we have reached the next stage of the government's roadmap for easing the restrictions, we have modified our guidance. It remains focused on the need to give careful consideration to any communications with HCPs and be sensitive to the challenges they are facing.Read the updated full statement
Industry associations and agencies are collecting and sharing
data on the impact of the COVID-19 pandemic on our ability to carry out primary
market research and this is one of a series of updates that we are publishing
to make sure that this information reaches our members.
A BHBIA Fieldwork Forum meeting took place on 11th
May, via WebEx and included a presentation from Nada Sahinagic, KeyQuest Health
and Adam Irwin, GKA. Nada and Adam shared the journey we have experienced with
respondents working in the NHS since the beginning of March and looked into
what we are expecting to see in the coming months.
The presenters have kindly provided a summary of some of the key findings and given us their permission to share this.Read our summary report
Feedback from the second EphMRA webinar providing an update on conducting fieldwork in major European markets, including the UK
The BHBIA has previously reported on webinars conducted earlier in April by EphMRA and Intellus Worldwide.
EphMRA conducted a second webinar on 30 April and kindly invited BHBIA members to attend once again. Our update focuses on key messages from the update that are relevant for the UK.Read our summary report
Industry associations and agencies are collecting and sharing data on the impact of the Covid-19 pandemic upon our ability to carry out primary market research and we want to make sure that this information reaches our members.
Two webinars took place during the week of 6 April:
- Primary Market Research Findings and Feasibility - Intellus Worldwide and M3 Global Research
- Update on Fieldwork in 5EU - EphMRA and a range of agencies, including M3, Medefield and a UK perspective from KeyQuest Health
The hosts and presenters have kindly allowed the BHBIA to share some of the key findings, so with their permission we have collated and summarised key information:Read our summary report
EphMRA conducted a second webinar on 30 April and kindly invited BHBIA members to attend once again. We have provided a short summary of the points from this update that are relevant for the UK: click here to read the update.
MRS has updated the suite of MRS guidance interpreting
the implications for face-to-face data collection following the various
announcements of the easing of restrictions across the four nations of the UK.
The updated MRS guidance sets out the conditions for limited resumption of face-to-face data collection activities. There are variations between the four nations, particularly Scotland’s Protection Level system, and separate guidance has been drafted to address this.
The fundamental principle underlying this guidance is that face-to-face data collection will only be undertaken when no other alternative methodology can be used. This principle should be followed until the working from home and social contact messaging evolves.
Two new papers have been added to the MRS Coronavirus Support Hub.
The first paper makes the case for new investment from government in F2F, as well as restarting existing projects.
The second paper encourages government to allow more flexibility for over 70s to resume their normal social contact. This will enable the large proportion of F2F researchers in this age group to work, as well as ensuring that over 70s are represented in F2F research.Visit MRS website for details
Links to a series of resources, FAQs and third party guidance including:
- BSI : Best practice standards to help UK businesses
- KPMG: Guidance on the government support package and how to make your business resilient
- PwC: Support for UK businesses affected by the economic impact of coronavirus (COVID-19)
The guidance also refers to support for researchers from the Market Research Benevolent AssociationVisit MRS online support blog
Various research trackers and studies have been launched over the past few weeks as research organisations seek to understand consumer attitudes and behaviour during the Covid-19 outbreak. Here, Research Live will provide a list of Covid-19 focused trackers and research studies that we know have launched, with a focus on the UK market. This page will be updated and new research projects can be submitted for inclusion.Visit Research Live website
'Promoting an ethical approach to the business of market research and data analytics in difficult times'
Jane Frost, Chief Executive Officer of Market Research Society recently wrote to MRS members and referred to ‘ethical business practices’ to help the market research and data analytics industries.View a summary of the points made
Business Intelligence Associations - International
- Take an ethical approach.
- Some specialities should be avoided for market research but other specialities are available.
- Be flexible and keep in touch with country developments.
ESOMAR's centralised COVID-19 resources page, summarises all current initiatives they are running to support the research community, as well as offering guidance and industry content on the topic.
There are a number of practical reports which you may find useful, including:
- Financial Viability
- Covid-19 Business Planning and Strategy
- Impact of Covid-19 on Research Quality?
- Focus groups, where do we go from here?
- Successfully switching to purely online research methodologies, tips and solutions
- Successfully switching to a virtual office, tips and solutions you can use to go virtual and data protection and privacy tips
“Research has always been the cornerstone of informed decisions; why not lean on that expertise now and ensure evidence-based decision making and accelerate the termination of the crisis and the recovery post-crisis?”
ESOMAR is calling upon business leaders who commission research, national government leaders, international bodies, and the business community to take steps to facilitate access and dissemination of our expertise. The document outlines their recommendations.Read the ESOMAR document
- Essential research should be encouraged to continue
- Where possible, shifting to digital methodologies is part of our duty of care
- Physical proximity to be avoided at all possible cost. Where unique and exceptional circumstances apply, abide by ALL local guidance.
'Healthcare Providers Across Specialty Still Want to Participate in Market Research' (March 25): Draws on research studies and says ‘let the data guide you when conducting research during the time of COVID-19’.
An update 'Primary Market Research Can Continue' (April 8) provides further data from multiple studies.Visit Intellus website for details
Data Protection Regulators
Helping individuals and organisations navigate data protection during this unprecedented time. The ICO will add new and relevant information as the pandemic continues. Includes sections on:
- Data Protection and coronavirus – what you need to know – providing answers to the questions the ICO are being asked (for example advice to apply usual security measures for homeworking to keep personal data safe).
- Advice for healthcare professionals.
Pharmaceutical Industry Associations
The Association of the British Pharmaceutical Industry is working closely with the Department of Health and the NHS on how our members can best support the Government as plans evolve and we adapt to an ever-changing situation.
The ABPI's COVID-19 hub gives access to the most up-to-date information for what pharmaceutical companies are doing to tackle the outbreak.Visit ABPI website for details
BHBIA member companies (research and trackers)
Creation.co are producing a series of updates, webinars and videos based on their understanding of what healthcare professionals are saying online about the impact of Covid-19. Creation.co track and analyse the conversations of more than 1.9m healthcare professional social media profiles worldwide.Visit CREATION.co website for latest updates
Following the research GKA conducted in April with their panel of healthcare professionals, they share an updated picture of how the situation is looking now, particularly as the measures in place across society are beginning to change.Visit GKA website for details
KQH produces a daily update on the feasibility of conducting research with HCPs in the USA, UK, France, Germany, Italy, Spain, Japan, China & Korea.Visit the KQH website for latest updates
M3 Global Research have surveyed over 31,000 HCPs globally about their current willingness to participate in market research.
The study results (currently updated daily) can be accessed in the form of an interactive dashboard (filtered by country, HCP type and specialty), and as a PDF report, on their website.Visit M3 website for details
Sermo invited its 1,3MM HCPs to participate in the COVID-19 Real Time Barometer Study, which addresses a broad range of topics including treatments, their efficacy and safety, ethical questions related to wartime triaging, medical shortages, patient types experiencing the most complications, hospital preparedness, peak timing, social distancing impact and more. Multiple waves including a deeper dive into treatments will be conducted over the next several weeks.Visit Sermo website for key findings and further information